(AQB) AquaBounty Technologies, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(AQB) AquaBounty Technologies, Inc. Complete Analysis Pack
Download Your Competitive Advantage
This AquaBounty Technologies, Inc. 4P's Marketing Mix Analysis explains the company’s GMO salmon product, its use in supplying sustainable seafood, and how Product, Price, Place, and Promotion work together; the page shows a genuine preview/sample of the analysis so you can evaluate style and content before buying—purchase the full version to get the complete ready-to-use report.
Product
AquAdvantage Salmon
AquAdvantage Salmon is AquaBounty Technologies, Inc.'s flagship product: a genetically engineered Atlantic salmon for human consumption and the core proof of its biotech model. It was the first genetically engineered animal approved by the U.S. FDA for food, with approval in 2015. That product identity is the whole brand story for AquaBounty Technologies, Inc.
Conventional Atlantic salmon
AquaBounty Technologies, Inc. also offers non-GE Atlantic salmon, so the product line is not limited to its flagship fish. That matters in a market where global Atlantic salmon supply stays above 3 million metric tons a year, because it gives buyers a clear choice between conventional and bioengineered options. This wider mix can help AquaBounty reach more seafood buyers and retail channels.
Salmon eggs
AquaBounty Technologies, Inc. sells salmon eggs as an upstream input in its aquaculture supply chain, feeding the first step of fish production. The product fits the company’s commercial fish-farming focus because eggs are the source stock for hatchery output and later grow-out sales. In aquaculture, the egg stage is critical since survival and hatch rates shape downstream yield and unit economics.
Juvenile fish fry
AquaBounty Technologies, Inc. sells juvenile fish fry as production input for aquaculture grow-out cycles, not as end-market seafood. In its latest 2025 filings, the Company’s commercial footprint was limited as it wound down operations, so fry remained a portfolio input tied to farming use rather than a scaled revenue driver.
- Fry start grow-out cycles
- Production input, not final food
- 2025 commercial scale was limited
Research outputs
AquaBounty’s research outputs focus on genetics, genomics, fish health, and nutrition, which support product design and better farm performance.
That biotech-led work helps improve growth traits, feed use, and animal health, tying science directly to production efficiency.
- Genetics and genomics guide selective breeding.
- Fish health lowers loss risk.
- Nutrition supports faster, efficient growth.
AquaBounty’s Biotech Salmon and R&D Portfolio in 2025
AquaBounty Technologies, Inc.'s product mix is centered on AquAdvantage Salmon, the first U.S. FDA-approved genetically engineered animal for food, plus non-GE Atlantic salmon, eggs, fry, and R&D outputs. In 2025, operations were limited as the Company wound down. Global Atlantic salmon supply topped 3 million metric tons, keeping the category large.
| Product | 2025 note |
|---|---|
| AquAdvantage Salmon | Flagship biotech food fish |
| Non-GE salmon, eggs, fry | Limited scale, supply-chain inputs |
| R&D outputs | Genetics, health, nutrition |
What is included in the product
Detailed Word Document
Delivers a concise, company-specific breakdown of AquaBounty Technologies, Inc.’s Product, Price, Place, and Promotion strategy with real-world market context.
Editable Excel File
Summarizes AquaBounty’s 4Ps into a clear, at-a-glance format that quickly eases marketing analysis and team alignment.
Reference Sources
Lists primary, reputable sources for AquaBounty—industry reports, regulatory filings, and datasets—so investors can quickly verify assumptions and speed due diligence.
Place
Maynard, Massachusetts headquarters
AquaBounty Technologies, Inc. is headquartered in Maynard, Massachusetts, about 25 miles west of Boston. The site anchors corporate operations and houses management and administration, so it is the company’s main control center for decision-making and coordination. For the Place element, this single U.S. headquarters supports a lean operating model and centralizes oversight of the business.
United States and Canada focus
AquaBounty Technologies, Inc. focuses on the United States and Canada, serving commercial fish farming in North America, where the U.S. imports about 80% of its seafood and Canada’s farmed seafood sector is a multibillion-dollar market. This two-country footprint keeps sales tied to nearby aquaculture hubs, cold-chain logistics, and regional food buyers. That makes North America the company’s core geographic reach.
Prince Edward Island site
AquaBounty Technologies, Inc. has operated its Prince Edward Island site in Canada as part of its salmon production system, tying local farming capacity to North American supply needs. The site helped the company build a shorter supply chain for fresh Atlantic salmon. It was one of AquaBounty’s core production assets before the company’s later restructuring moves.
Indiana grow-out facility
Indiana grow-out facility is AquaBounty Technologies, Inc.'s U.S. land-based salmon site in Albany, Indiana. Built to serve the nearby U.S. market, it cut transport miles and supported fresher supply. The farm was designed for about 1,200 metric tons a year, showing the company’s recirculating aquaculture system model in action.
- U.S.-market proximity
- Land-based salmon production
- Designed for 1,200 metric tons
B2B aquaculture distribution
AquaBounty Technologies, Inc. sells into commercial aquaculture, not consumer retail, so its distribution runs through B2B supply channels like fish farms and industry buyers. That fits its role as a fish-farming technology and supply company, where value comes from selling eggs, stock, and production know-how to operators, not from shelf-ready branded food.
- B2B channel, not retail
- Serves commercial fish farms
- Matches technology-led model
AquaBounty’s Tight North American Supply Strategy
AquaBounty Technologies, Inc. uses a tight North American Place strategy: one corporate HQ in Maynard, Massachusetts, plus production and supply links in the U.S. and Canada. Its Indiana farm was built for about 1,200 metric tons a year, showing a local, land-based model aimed at fresher delivery. The channel stays B2B, not retail.
| Place factor | Data |
|---|---|
| HQ | Maynard, Massachusetts |
| Indiana site | ~1,200 metric tons/year |
| Market | U.S. and Canada |
What You See Is What You Get
AquaBounty Technologies, Inc. Reference Sources
The preview shown here is the actual, full Marketing Mix analysis for AquaBounty Technologies, Inc. you’ll receive instantly after purchase—no samples or mockups, just the finished, editable document ready for immediate use.
Promotion
FDA approval 2015
AquaBounty Technologies, Inc. won U.S. FDA approval for AquAdvantage Salmon in 2015, a first-in-class regulatory win that it used as a core promotion point. The approval gave AquaBounty Technologies, Inc. public credibility, helped reduce safety concerns, and set it apart in a market where no other genetically engineered animal had cleared U.S. food review.
Health Canada approval 2016
Health Canada approved AquaBounty Technologies, Inc.'s AquAdvantage Salmon in 2016, adding a second North American regulator after the U.S. FDA in 2015. That gave the product stronger legitimacy for food safety and biotech acceptance. It also backed AquaBounty Technologies, Inc.'s market story as the first approved genetically engineered salmon for human consumption in Canada and the U.S.
Productivity messaging
AquaBounty Technologies, Inc. sells its salmon as a productivity tool for commercial fish farms, with messaging built around higher output and better feed use. That positioning turns the product into an aquaculture efficiency play, not just a seafood brand. Its core story is simple: produce more fish with fewer inputs and tighter farming control.
Scientific positioning
AquaBounty’s scientific positioning centers on genetics, genomics, fish health, and nutrition, which frames the Company as a biotech-led salmon producer, not a conventional aquaculture player. That message supports differentiation by tying growth, feed efficiency, and fish welfare to science-backed breeding and nutrition.
- Biotech branding over commodity salmon
- Science-led fish health and nutrition
- Clear gap vs. traditional producers
Corporate communications
AquaBounty Technologies, Inc. uses corporate communications as its main promotion tool, with press releases and investor updates on regulatory, scientific, and business milestones. That fits a biotech model with a narrow, specialized product, where credibility matters more than mass-market ads. In 2024, the Company reported $0 revenue and a net loss of $54.4 million, so messaging has focused on financing, approvals, and execution.
- Press releases drive awareness
- Investor updates support trust
- Science and regulatory news lead
- Promotion fits niche biotech
AquaBounty’s Pitch: Regulatory Trust, Not Revenue
AquaBounty Technologies, Inc. promotes AquAdvantage Salmon through FDA and Health Canada approvals, using regulation as proof of safety and legitimacy. Its message centers on biotech-led efficiency: more output, better feed use, and tighter farming control. In 2024, the Company reported $0 revenue and a $54.4 million net loss, so promotion stayed focused on trust, science, and financing.
| Key promotion signal | Latest figure |
|---|---|
| 2024 revenue | $0 |
| 2024 net loss | $54.4 million |
| U.S. FDA approval | 2015 |
| Health Canada approval | 2016 |
Price
No public list price
AquaBounty Technologies, Inc. does not publish a consumer shelf price because its core sales are aimed at commercial buyers, not retail shoppers. In its latest reporting period, pricing was negotiated B2B, so it is not shown like a grocery seafood brand. That keeps the model tied to bulk contracts and supply agreements.
Business-to-business sales
AquaBounty Technologies, Inc. sells mainly to commercial aquaculture and seafood buyers, so pricing is set through direct commercial deals, not shelf labels. That makes prices less visible than in retail and usually tied to order size, contract terms, and customer specs. In B2B fish sales, this means margins can shift with volume and logistics costs.
Value-based positioning
AquaBounty Technologies, Inc. uses value-based pricing because AquAdvantage Salmon’s value comes from its biotechnology traits, not commodity fish pricing. The salmon is engineered to reach market size in about 18 months versus about 36 months for conventional Atlantic salmon, which supports a productivity-focused price premium. That efficiency helps buyers weigh faster turnover, lower feed use, and more predictable supply against the higher price.
Production cost sensitivity
AquaBounty Technologies, Inc. pricing is highly sensitive to farming, feed, and facility costs because land-based aquaculture is capital intensive and fixed costs stay high even when output is uneven. In recirculating aquaculture systems, unit economics hinge on keeping feed conversion, mortality, power, and labor under control, so small cost swings can pressure gross margin fast.
- Feed and power drive unit cost
- Facility capex lifts break-even price
- Higher yield lowers cost per pound
Multiple product types
AquaBounty Technologies, Inc. prices salmon, eggs, fry, and byproducts separately, so revenue comes from a mixed basket, not one fixed price. Fresh salmon can command the highest unit price, while eggs and fry are priced as inputs for growers and downstream sales. That mix lets AquaBounty spread risk and adjust pricing by product stage and demand.
- Salmon: premium finished product
- Eggs: seed-stage pricing
- Fry: volume-based pricing
- Byproducts: extra revenue stream
AquaBounty’s B2B Pricing: No Shelf Tag, Contract Value Drives Sales
AquaBounty Technologies, Inc. does not publish a retail shelf price; its sales are negotiated B2B. Price reflects contract size, customer specs, and logistics, not a fixed consumer tag. Value pricing supports AquAdvantage Salmon’s faster 18-month grow-out vs about 36 months for conventional Atlantic salmon.
| Price item | Latest known |
|---|---|
| Public shelf price | Not disclosed |
| Model | B2B contract pricing |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.